#ThinkSabio Latest News
Disc Medicine has had a successful Type C meeting with the FDA for Bitopertin in EPP and plans to submit an NDA.
Disc Medicine has had a successful Type C meeting with the FDA for Bitopertin in EPP and plans to submit an NDA.